Scinovias mission is to produce state-of-the-art diagnostics to help doctors make more data-driven decisions during procedures to save more lives. Scinovia developed VUFLOW, the future of non-contact imaging diagnostics for blood flow during surgery.
Assessing the blood flow for surgery is challenging and costly. A top challenge surgeons face is knowing whether a procedure has poor blood flow. The number one problem surgeons face is knowing whether a procedure has poor blood flow. 20% of bypass grafts have less than 50% of average blood flow and 14% of breast reconstruction have necrosis. These cases add up: it costs around $100k per case to address breast tissue necrosis.